Drug Pipeline

Caffeine Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
7
Active Studies
2
Recruiting
1
Phase 3
6
Top Sponsors
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-05-23 NCT07305935
Comparison of Early Caffeine Administration Vs Supportive Therapy in Preventing Acute…		 Trial completed
Active Studies by Phase
Phase 3
1
Phase 2
1
Phase 1/2
1
Early Phase 1
1
Not specified
3
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT04570085 Effect of CAFfeine on Cognition in Alzheimer's Disease Alzheimer Disease Recruiting
Phase 2
NCT07456670 Caffeine for Infants Born at 28 to 34 Weeks Receiving Respiratory Support Preterm Birth Not Yet Recruiting
Phase 1/2
NCT07469852 Effects of Caffeine Ingestion on Morning Cognitive and 4-km Time Trial Performance in… Caffeine Active, Not Recruiting
Early Phase 1
NCT07466732 Effects of Caffeine Ingestion on Morning Cognitive and Muscle Repeated Sprint Performance… Caffeine Enrolling by Invitation
Not specified
NCT06978777 Effect of Caffeine on Cold-stimulated Brown Adipose Tissue Activity Brown Adipose Tissue (BAT) Physiology Recruiting
NCT00961792 Chicago Social Drinking Project Alcoholism Active, Not Recruiting
NCT07402902 Caffeine Strategies and Fat Oxidation Fat Metabolism Enrolling by Invitation
Sponsors Running Caffeine Trials
Liverpool John Moores University (2) University of Chicago (1) University Hospital, Lille (1) University Hospital, Basel, Switzerland (1) Universidad Rey Juan Carlos (1) Queen's University (1)
Disease Areas
Alzheimer's Disease (1)
Get alerts when Caffeine trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free